| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Andrew Regan
Also a director
Chief Executive Officer and Director
|
60 | Not stated | Not stated | $8,168,796 | |
|
James Bligh
Also a director
Chief Financial Officer and Director
|
38 | Not stated | Not stated | $1,450,922 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Director travel expenses payable to Dr. Regan
PIPE subscription for shares and PIPE Warrants concurrent with the Merger
Sale of Conduit Pharmaceuticals Limited (CPL), including litigation liability, to Corvus, satisfied through issuance of Common Stock and Pre-Funded Warrants
Senior Secured Promissory Note issued by the Company to Nirland (August 2024 Note)
Personal guarantee by Dr. Regan of the August 2024 Nirland Note
Promissory note issued by the Company to Nirland (October 2024 Nirland Note)
Services Agreement for algorithmic and cybernetic technology services, with milestone and ongoing service fees
Additional license and use agreement for additional deliverables and analysis of acquired AstraZeneca assets
Second Addendum expanding scope to integrate a Cryptocurrency AI Agent; initial consideration
Company agreed to acquire approximately 20% of Sarborg for Common Stock, pre-funded warrants and cash consideration
Company agreed to acquire 270 shares (approximately 4.76%) of Sarborg in exchange for pre-funded warrants
Joint Development Agreement granting Manoira a license to CDT Assets; CDT issued Common Stock as consideration
Private placement of warrants to third parties including certain directors, in exchange for a lock-up
Loading...
